KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Equity Average (2016 - 2025)

Historic Equity Average for Idexx Laboratories (IDXX) over the last 16 years, with Q3 2025 value amounting to $1.5 billion.

  • Idexx Laboratories' Equity Average fell 557.46% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 557.46%. This contributed to the annual value of $1.5 billion for FY2024, which is 4713.09% up from last year.
  • Latest data reveals that Idexx Laboratories reported Equity Average of $1.5 billion as of Q3 2025, which was down 557.46% from $1.5 billion recorded in Q2 2025.
  • Idexx Laboratories' 5-year Equity Average high stood at $1.6 billion for Q4 2024, and its period low was $466.5 million during Q3 2022.
  • Its 5-year average for Equity Average is $1.1 billion, with a median of $967.5 million in 2023.
  • In the last 5 years, Idexx Laboratories' Equity Average surged by 36740.94% in 2021 and then tumbled by 3795.19% in 2022.
  • Over the past 5 years, Idexx Laboratories' Equity Average (Quarter) stood at $722.7 million in 2021, then dropped by 24.96% to $542.4 million in 2022, then skyrocketed by 156.46% to $1.4 billion in 2023, then increased by 15.51% to $1.6 billion in 2024, then fell by 6.02% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.5 billion for Q2 2025, and $1.5 billion during Q1 2025.